Phase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer
Clinical trial NCT05580172 · UNKNOWN
Trial details
- NCT number
- NCT05580172
- Sponsor
- ReHeva Biosciences,Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-06-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.